ICL Israel Chemicals Ltd (United States) is listed on the Nasdaq and has a market capitalization of $6.69 Billions, with shareholders equity totaling $6.24 Billions.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, ICL Israel Chemicals Ltd reported $7.15 Billions in revenue, generating net income of $226.00 Millions.
Key financial metrics include a P/E ratio of 29.59, a price-to-book (P/B) ratio of 1.07, and a trailing twelve-month dividend yield of 3.47%.
The company trades under the ticker ICL.